This document discusses HIVAN (HIV Associated Nephropathy) and TDF (tenofovir disoproxil fumarate) induced nephropathy. HIVAN occurs in advanced HIV disease and causes rapid progression to end-stage renal disease. It predominantly affects young black males and has a distinct histology. TDF is an antiretroviral medication that can accumulate in kidney cells and impair mitochondrial DNA, potentially leading to proximal tubular dysfunction or Fanconi syndrome. The document provides statistics on HIVAN and outlines the pathophysiology, clinical presentation, and recommendations regarding both conditions.
6. HIVAN
• HIVAN occurs in advanced HIV disease and is classically
associated with rapid progression to end-stage renal
disease (ESRD).
• HIVAN has a distinct histology, representing a collapsing
form of focal segmental glomerulosclerosis (FSGS)
• Affects mostly young black males, 10: 1 Male to female
ratio
7. Characteristics of HIVAN
• Azotemia
• Nephrotic range
Proteinuria
• Normal serum
complement
levels,
microhematuria
• Normal to large
kidneys on
Ultrasound
• FSGS on renal
Biopsy
9. • HIV 1, infects the renal glomerular and tubular epithelial
cells. The exact mechanism of remains unclear but one
study stipulates that IL6 & TNFa were shown to be potent
stimuli for HIV1 expression in HIV1 Infected monocytes
which play a role in HIVAN.
• Histopathological features include: enhanced
proliferation and loss glomerular epithelial cells which
lead to glomerulosclerosis, tubulainterstitial scarring.
• Prognosis: halted by HAART
• Treatment with ACEI may be beneficial & steroids
10. • Prognosis: halted by HAART
• Treatment with ACEI may be beneficial &
steroids
12. • Tenofovir disoproxil fumarate is a bioavailable
prodrug of tenofovir, a potent acyclic
nucleotide analogue reverse-transcriptase
inhibitor with activity against HIV and
hepatitis B virus.
• TAF (tenofovir Alafenamide fumarate)
• Administered 300-mg once daily.
13. • Eliminated unchanged in Urine by glomerular filtration
& proximal tubular secretion.
• 20-30% is actively transported into renal proximal
tubule cells by organic anion transporter (LOAT1) and
to a lesser extent in the basolateral membrane.
• Subsequently it’s secreted into the tubular lumen by
apical membrane transporter MRP4&2.
• Several drugs may interact with these transporters and
may cause exessive entry or reduced outflow of TDF
favoring intracellular accumulation and renal toxicity.
14. • Acyclic NRTIs impair mitochondrial DNA
(mDNA) replication by inhibiting
mitochondrial DNA polymerase.
15. Clinical Presentation
• Proximal tubular dysfunction, with preserved
renal function
• Proximal tubular dysfunction with impaired
renal function
• Fanconi Like Syndrome
16. • In its complete form:
– Renal tubular acidosis
– Hypouricemia
– Tubular proteinuria
– Normoglycaemia but glycosuria
– Aminoaciduria
– Hypophosphataemia
18. References
• NAMIBIA POPULATION-BASED HIV IMPACT ASSESSMENT
NAMPHIA 2017
• Namibian GUIDELINES NATIONAL GUIDELINES FOR
ANTIRETROVIRAL THERAPY, 2016. 5th Edition
• Sean R. Hosein, nov 2015. TAF vs. TDF (original tenofovir)—
improvements in safety.
https://www.catie.ca/en/treatmentupdate/treatmentupdat
e-211/anti-hiv-agents/taf-vs-tdf-original-tenofovir-
improvements-safet
Editor's Notes
NAMIBIA POPULATION-BASED HIV IMPACT ASSESSMENT NAMPHIA 2017
Other reported glomerular lesions in patients with HIV include IgA nephropathy, cryoglobulinemia, amyloidosis, and a lupuslike immune complex glomerulopathy
Azotemia increase in nitrogen containing compounds in the blood
Proteinuria > 2g/m^2/24 hours (spot urine > 30mg)
SIADH: hyponatraemia, high k, fluid overload
HIV 1, infects the renal glomerular and tubular epithelial cells. The exact mechanism of remains unclear but one study stipulates that IL6 & TNFa were shown to be potent stimuli for HIV1 expression in HIV1 Infected monocytes which play a role in HIVAN.
Histopathological features include: enhanced proliferation and loss glomerular epithelial cells which lead to glomerulosclerosis, tubulainterstitial scarring and proteinuria.